Abstract
Title: Unexpected survivorship: Problems and supportive care needs of advanced melanoma survivors.
Background: Of the advanced melanoma patients 22% can now become a survivor because of the approval of the treatment with ipilimumab in 2011. This unexpected survivorship encompasses managing the long-term consequences of the disease and/or treatment. Providing supportive care
... read more